Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 - Chemours Co | cc-ex21_20151231xq4.htm |
| EX-31.1 - EXHIBIT 31.1 - Chemours Co | cc-ex311_20151231xq4.htm |
| EX-10.26 - EXHIBIT 10.26 - Chemours Co | cc-ex1026_20151231xq4.htm |
| EX-10.27 - EXHIBIT 10.27 - Chemours Co | cc-ex1027_20151231xq4.htm |
| EX-10.28 - EXHIBIT 10.28 - Chemours Co | cc-ex1028_20151231xq4.htm |
| EX-32.1 - EXHIBIT 32.1 - Chemours Co | cc-ex321_20151231xq4.htm |
| 10-K - 10-K - Chemours Co | cc-20151231x10k.htm |
| EX-31.2 - EXHIBIT 31.2 - Chemours Co | cc-ex312_20151231xq4.htm |
| EX-32.2 - EXHIBIT 32.2 - Chemours Co | cc-ex322_20151231xq4.htm |
| EX-95 - EXHIBIT 95 - Chemours Co | cc-ex95_20151231xq4.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-8 (Nos. 333-205391, 333-205393, 333-205392) of The Chemours Company of our report dated February 25, 2016 relating to the financial statements and financial statement schedule, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 25, 2016